Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 36,632 | 32,578 | -15,210 | -21,120 | 32,641 |
| Depreciation Amortization | 19,481 | 17,209 | 15,880 | 14,425 | 10,390 |
| Income taxes - deferred | 3,098 | 2,019 | N/A | N/A | N/A |
| Accounts receivable | 430 | -10,406 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -8,534 | -7,169 | N/A | N/A | N/A |
| Other Working Capital | -31,618 | 813 | 8,230 | 5,394 | -35,055 |
| Other Operating Activity | 8,751 | 17,575 | 37,170 | 14,800 | 0 |
| Operating Cash Flow | $28,240 | $52,619 | $46,070 | $13,499 | $7,976 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 43,156 | -25,765 | N/A | N/A | N/A |
| PPE Investments | -15,520 | -8,292 | -8,990 | -12,507 | -11,784 |
| Net Acquisitions | 10,400 | 350 | -39,090 | -23,047 | -19,709 |
| Purchase Sale Intangibles | -11,945 | -4,088 | N/A | N/A | N/A |
| Other Investing Activity | -13,811 | -5,317 | -320 | 2,816 | -6,975 |
| Investing Cash Flow | $24,225 | $-39,024 | $-48,400 | $-32,738 | $-38,468 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,229 | 6,611 | N/A | N/A | N/A |
| Common Stock Repurchased | -70,257 | -64,222 | N/A | N/A | N/A |
| Other Financing Activity | -3,322 | -6,411 | 3,220 | 1,539 | 9,969 |
| Financing Cash Flow | $-63,350 | $-64,022 | $3,220 | $1,539 | $9,969 |
| Exchange Rate Effect | -1,684 | -60 | 1,190 | -3,069 | -987 |
| Beginning Cash Position | 58,576 | 109,063 | 106,970 | 127,741 | 149,252 |
| End Cash Position | 46,007 | 58,576 | 109,060 | 106,972 | 127,741 |
| Net Cash Flow | $-12,569 | $-50,487 | $2,090 | $-20,769 | $-21,511 |
| Free Cash Flow | |||||
| Operating Cash Flow | 28,240 | 52,619 | 46,070 | 13,499 | 7,976 |
| Capital Expenditure | -15,520 | -8,292 | N/A | N/A | N/A |
| Free Cash Flow | 12,720 | 44,327 | 46,070 | 13,499 | 7,976 |